Glucose B. Braun (Glucose Monohydrate)

Glucose B. Braun is indicated for several clinical situations where rapid carbohydrate delivery or fluid replacement is needed.

• Treatment of hypoglycemia when oral glucose is not feasible
• Fluid and electrolyte replacement in patients requiring intravenous therapy
• Component of parenteral nutrition regimens to provide caloric support
• Maintenance of intraoperative blood glucose levels during surgery
• Management of metabolic stress in critically ill patients

When administered intravenously, Glucose B. Braun can produce a range of physiological responses, most of which are related to its carbohydrate content.

Common

• Transient hyperglycemia
• Local irritation or phlebitis at the infusion site
• Mild electrolyte shifts such as hypernatremia
• Nausea or mild gastrointestinal discomfort
• Headache
• Low-grade fever

Serious

• Severe hyperglycemia requiring medical intervention
• Osmotic diuresis leading to dehydration
• Anaphylactic or severe allergic reaction
• Marked electrolyte disturbances (e.g., hyperkalemia)
• Metabolic acidosis in susceptible patients

Safe use of Glucose B. Braun requires attention to patient-specific factors and proper administration techniques.

• Monitor blood glucose levels regularly during infusion
• Adjust infusion rate in patients with diabetes or impaired glucose tolerance
• Avoid use in patients with uncontrolled severe hyperglycemia
• Use caution in individuals with renal or hepatic impairment
• Ensure compatibility with other IV solutions before mixing
• Observe the catheter site for signs of infection or phlebitis
• Consider risk of fluid overload in patients with heart failure

Glucose B. Braun may interact with other intravenous therapies, affecting glucose balance or solution compatibility.

Avoid

• Concurrent high‑dose insulin infusions without close glucose monitoring
• Co‑administration with hypertonic saline solutions that may exacerbate electrolyte shifts
• Mixing with calcium‑containing solutions that can precipitate
• Use with certain potassium supplements without electrolyte monitoring
• Simultaneous infusion with incompatible drugs such as some antibiotics

Use with caution

• Concurrent administration of other dextrose‑containing fluids
• Use with diuretics that alter electrolyte status
• Infusion alongside catecholamines that may raise blood glucose
• Co‑administration with glucocorticoids that increase glucose production
• Inclusion in total parenteral nutrition admixtures requiring careful calculation